Filing Details
- Accession Number:
- 0001348362-25-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-30 11:14:34
- Reporting Period:
- 2025-07-29
- Filing Date:
- 2025-07-30
- Accepted Time:
- 2025-07-30 11:14:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348362 | Lexaria Bioscience Corp. | LEXX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1271244 | Richard Christopher | C/O Lexaria Bioscience Corp. 100 - 740 Mccurdy Road Kelowna A1 V1X 2P7 | Chief Executive Officer | Yes | Yes | No | No |
Transaction Summary
| Purchased: | 15,000 shares | Avg. Price: $0.91 | Total Value: $13,641.00 |
| Number of Shares After Transactions: | 65,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2025-07-29 | 15,000 | $0.91 | 65,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 50,000 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Options | $3.92 | 2025-02-28 | 2029-08-31 | 200,000 | 200,000 | Direct |
| Common Shares | Stock Options | $1.04 | 2025-05-15 | 2030-05-15 | 150,000 | 350,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-08-31 | 200,000 | 200,000 | Direct |
| 2030-05-15 | 150,000 | 350,000 | Direct |
Footnotes
- 50,000 options were exercisable on Feb. 28, 2025, an additional 6,818 options are exercisable every month thereafter until November 30, 2026 whereby the balance of 6,822 options will be exercisable December 31, 2026
Billionaire Hedge Funds
